Archive | Conferences & Symposiums

One-Third of Patients With Advanced Melanoma Survive at Least 5 Years After Nivolumab Treatment

The news is good from the longest follow-up survival study of patients with advanced melanoma who were treated with the anti–programmed cell death protein 1 (PD-1) agent nivolumab (Opdivo).1 Thirty-four percent of patients who received the drug in a phase I trial (CA909-003) were alive 5 years later. This study, which was presented at the […]

Read the full story

Posted in Melanoma In The News, Clinical Trials, Conferences & Symposiums

ASCO: More Good News for PD-1 Tx of Melanoma

CHICAGO — Patients with advanced melanoma treated with a PD-1 immune checkpoint inhibitor lived more than twice as long as historically treated patients, according to updated results from a large phase I clinical trial.

Read the full story

Posted in Melanoma In The News, Clinical Trials, Conferences & Symposiums

Targeted Checkpoint Blocking Therapies Not Yet an Effective Melanoma Treatment, Cancer Expert Says

In a talk at the recent HemOnc Today’s Melanoma and Cutaneous Malignancies meeting, Christian Blank, group leader of the division of immunology at Netherlands Cancer Institute, presented his views of checkpoint blocking therapies. He concluded that targeted therapy is not enough to fight melanoma.

Read the full story

Posted in Health Professionals, Conferences & Symposiums, Journals,Papers & Reports

VIDEO: Targeted therapy ‘not enough’ for long-term melanoma treatment

Christian Blank, MD, PhD, staff member in medical oncology and group leader of the division of immunology at Netherlands Cancer Institute, reviewed new checkpoint targets during a presentation at HemOnc Today Melanoma and Cutaneous Malignancies.

Read the full story

Posted in Health Professionals, Conferences & Symposiums, Videos

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories